Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.

Document types check

Please use this identifier to cite or link to this item: https://hdl.handle.net/20.500.12530/30507

Title:	Comparison of risk classification between EndoPredict and MammaPrint in ER-positive/HER2-negative primary invasive breast cancer.
Authors:	Peláez-García, Alberto Yébenes, Laura Berjón, Alberto Angulo, Antonia Zamora, Pilar Sánchez-Méndez, José Ignacio Espinosa, Enrique Redondo, Andrés Heredia-Soto, Victoria Mendiola, Marta Feliú, Jaime Hardisson, David View more
Mesh:	Breast Neoplasms Calcium-Binding Proteins Calmodulin Carrier Proteins Cytokine Receptor gp130 Extracellular Matrix Proteins Female Glycoproteins Humans Immunohistochemistry In Vitro Techniques Inhibitor of Apoptosis Proteins Intercellular Signaling Peptides and Proteins Ki-67 Antigen Middle Aged Oxidoreductases Acting on CH-CH Group Donors Proteins Receptor, ErbB-2 Receptors, Estrogen Receptors, Progesterone Ribosomal Proteins Survivin Ubiquitin-Conjugating Enzymes View more
Issue Date:	2017
Citation:	PLoS ONE.2017;(12)9:e0183452
Abstract:	To compare the concordance in risk classification between the EndoPredict and the MammaPrint scores obtained for the same cancer samples on 40 estrogen-receptor positive/HER2-negative breast carcinomas.
PMID:	28886093
URI:	https://hdl.handle.net/20.500.12530/30507
Rights:	openAccess
Appears in Collections:	Fundaciones e Institutos de Investigación > IIS H. U. La Paz > Artículos Hospitales > H. U. La Paz > Artículos

Files in This Item:

File	Description	Size	Format
PMC5590847.pdf		910.85 kB	Adobe PDF	View/Open